What Happened?
, -based Personalis Appointed Sherry Kan as Vice President, Marketing and Product Management
About the Company
Personalis, Inc. is partnering with biopharma to develop and commercialize the next generation of cancer immunotherapies. We provide advanced genomic sequencing and analytics for immuno-oncology. Our patented ACE (Accuracy and Content Enhanced) Technology forms the foundation of all Personalis products and makes it possible for us to achieve augmented coverage of difficult-to-sequence genomic regions often missed with the use of conventional sequencing techniques, for more comprehensive and accurate genomic data. ACE ImmunoID, our universal platform for immuno-oncology, combines augmented whole exome and transcriptome assays with analytics that capture neoantigens, elucidate the tumor microenviroment, and identify mechanisms of tumor escape.
About the Person
Sherry Kan is Vice President, Marketing and Product Management at Personalis. Previously, Sherry held various senior HR leadership roles in the industry.
Info Source
News
Short Profile